In short
Cilastatin is a drug that has been the subject of several clinical trials, often used in combination with other antibiotics to treat various bacterial infections. This article explores the use of cilastatin in clinical trials, focusing on its efficacy, safety, and potential applications in treating conditions such as urinary tract infections, pneumonia, and other bacterial infections.
At a glance
- Main Uses
- Cilastatin is primarily used in combination with other antibiotics, especially imipenem, to treat various bacterial infections
- Infections Studied
- Complicated urinary tract infections, hospital-acquired pneumonia, ventilator-associated pneumonia, intra-abdominal infections
- Administration
- Typically administered intravenously in clinical trials
- Dosage
- Varies depending on the specific infection and patient condition
- Treatment Duration
- Ranges from 5 to 14 days in most studies
- Safety Monitoring
- Adverse events, laboratory values, vital signs, and other safety parameters are closely monitored
- Potential Benefits
- May enhance antibiotic effectiveness by preventing kidney breakdown, potentially improving treatment of serious bacterial infections
- Ongoing Research
- Studies are exploring cilastatin's efficacy, safety, and pharmacokinetics in various patient populations and infection types
What is Cilastatin?
Cilastatin is a medication that is typically used in combination with other antibiotics to treat various bacterial infections. It is not an antibiotic itself, but rather a supportive drug that helps other antibiotics work more effectively. Cilastatin is often referred to by its generic name, but it may also be found as part of combination drugs such as imipenem/cilastatin (brand name: PRIMAXIN®).
How Cilastatin Works
Cilastatin works by preventing the breakdown of certain antibiotics in the kidneys. This allows the antibiotic to remain active in the body for a longer period, increasing its effectiveness against bacterial infections. Specifically, cilastatin inhibits an enzyme in the kidneys called dehydropeptidase-I, which would otherwise break down antibiotics like imipenem.
Medical Uses of Cilastatin
Cilastatin is not used on its own to treat infections. Instead, it is combined with other antibiotics to treat various bacterial infections, including:
- Complicated urinary tract infections (cUTIs): These are infections that affect the bladder, kidneys, or other parts of the urinary system and are more difficult to treat than simple UTIs.
- Complicated intra-abdominal infections (cIAIs): These are infections that extend beyond the hollow organ of origin into the peritoneal space, causing either abscess formation or peritonitis.
- Hospital-acquired bacterial pneumonia (HABP): This is a lung infection that develops during a hospital stay, typically 48 hours or more after admission.
- Ventilator-associated bacterial pneumonia (VABP): This is a type of pneumonia that occurs in people who are on mechanical ventilation.
Combination Therapies with Cilastatin
Cilastatin is most commonly used in combination with other antibiotics. Some of the notable combinations include:
- Imipenem/Cilastatin: This combination is used to treat a wide range of bacterial infections. Imipenem is a powerful antibiotic, and cilastatin helps to prevent its breakdown in the kidneys.
- Imipenem/Cilastatin/Relebactam: This is a newer combination that includes relebactam, which helps to overcome certain types of antibiotic resistance. It's used for complicated urinary tract infections and complicated intra-abdominal infections.
How Cilastatin is Administered
Cilastatin is typically administered intravenously (through a vein) in a hospital or clinical setting. The dosage and duration of treatment can vary depending on the specific infection being treated and the patient's kidney function. For example:
- In some studies, imipenem/cilastatin was given as 500mg/500mg every 6 hours.
- In other cases, imipenem/cilastatin/relebactam was administered as 1.25g every 6 hours.
The exact dosage and schedule will be determined by your healthcare provider based on your individual needs and medical condition.
Current Clinical Trials
Several clinical trials are currently underway to further investigate the use of cilastatin in various combinations and for different conditions. Some of these include:
- A study examining the pharmacokinetics (how the drug moves through the body) of imipenem/cilastatin/relebactam in patients receiving extracorporeal membrane oxygenation (ECMO), a life support machine for patients with severe heart and lung failure.
- Research on a new combination therapy called imipenem/cilastatin/XNW4107 for treating hospital-acquired and ventilator-associated bacterial pneumonia.
Potential Side Effects
As with any medication, cilastatin and its combinations can cause side effects. Common side effects may include:
- Nausea or vomiting
- Diarrhea
- Headache
- Rash or itching
- Changes in liver function tests
More serious side effects, though rare, can occur. These may include severe allergic reactions, seizures, or changes in mental status. It's important to report any unusual symptoms to your healthcare provider immediately.
Special Considerations
There are some important factors to consider when using cilastatin:
- Kidney function: Since cilastatin affects kidney function, dosage adjustments may be necessary for patients with kidney problems.
- Allergies: Patients with a history of allergic reactions to beta-lactam antibiotics (like penicillins or cephalosporins) should use cilastatin combinations with caution.
- Pregnancy and breastfeeding: The safety of cilastatin during pregnancy and breastfeeding has not been fully established. Discuss the risks and benefits with your healthcare provider if you are pregnant or breastfeeding.